Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10, 2024.
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed to the eradication of all forms of lung cancer. The IASLC unites a diverse group of professionals – including medical, surgical, and radiation oncologists, as well as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient advocates, patients, and caregivers in – its mission to advance the science of lung cancer and enhance patient care.
Organized by the International Association for the Study of Lung Cancer (IASLC), this major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.
Here are some Highlights from the WCLC24:
“WCLC24 IASLC committee are rocking the social media and communications workshop !
Some highlights:
Estela Rodriguez: channel your inner Beyoncé
Mattew Smeltzer: demystify your data
Naomi Reguart: be the bridge between science and society.”
“Opening session at WCLC24 presented by the chairs Sandip Patel, Narjust Florez, Linda Martin, Fabio Moraes, president Dr. Paul Van Schil and CEO Karen Kelly. Very emotionally touching talk by Tomasa Ramirez and her daughter, our beloved Narjust.”
“Right now at the Advanced Cancer Survivorship session! Mariana Laloni from Grupo oncoclinicas is chairing.
Laura Petrillo will discuss Pall Care for Lung Cancer patients, and Paulo Bergerot will cover Exercise in Oncology. Don’t miss these insightful talks! Photo by Pedro De Marchi.”
“Why is my great colleague Mark Lewis – oncologist extraordinaire simply the best of the best?
I deliver tissue-agnostic and age-agnostic Precision Medicine talks, but Mark takes it one step further with ‘Species-agnostic Passionate Medicine’ talks!
Every oncology meeting needs an emotional support puppy that can double up as a sniff dog to detect early cancers.”
“WCLC24 Happening now! IASLC Career Development Committee’s IASLC grant workshop at RM22. Small group discussion is ongoing. If you missed it, come at 1:45PM for:
1. IASLC Grant Program Review
2. IASLC Grant Recipient’s experience
3. What’s an exceptional grant proposal”
“Very proud to see my dear friend Dr Oscar Arrieta director of The National Cancer Institute presenting at the WCLC24 plenary.
He is a terrific scientist, mentoring oncologists in Latin America and advancing the cancer research and care in LATAM.”
“Even if I don’t utter a word this is already shaping up to be the greatest presentation of my career.”
“Fantastic WCLC24 presentation on mobile Lung Cancer in Australia. First solar powered mobile screening in Australia. Exciting development for our forthcoming national LCS program from July 2025.”
“Why would someone from pharma attend a WCLC24 about Understanding and Managing Compassion Fatigue in Medical Practice? Because I care about patients and my medical colleagues. I want to be able to support them during the good times and bad.
What is compassion fatigue? It’s the brain protecting us from repeated assaults on our ability to be compassionate. We have to lean into wellness in our professional settings. Note: lunchtime yoga is not included.’
There are professional and personal tactics to address compassion fatigue. I personally think that having trainings in stress first aid and a resilience plan is a great start to propose in the workplace.”
“Fantastic IASLC STARS Scholars get-together! We ate, drank, laughed, and cried, remembering friends we have lost.
We all anxiously await the amazing research to be presented at WCLC24 – a lot of science on innovative treatments and talk about cures, BUT not as much about HELPING US LIVE BETTER.
Many of us are veteran patients – grateful to be alive but struggling with the compound cumulative effects of multiple lines of therapy. Our bodies are tired.
I implore all researchers who develop innovative treatments to also Make Cancer Less Shitty.”
“Excellent talk by Stephen V Liu on how to give a Master Class on Scientific presentations:
Key points:
– don’t make busy slides
– be aware of different and misaligned fonts
– don’t use a laser point!
– the data is the excellent! (Not you)
– be factual (help audience listen)”
“WCLC24 HEINE H. HANSEB LECTURESHIP AWARD for SMALL CELL LUNG CANCER to our friend and exceptional researcher Dr. Luis Paz-Ares. A well-deserved award for a pioneering researcher who has contributed to several cutting-edge advances in the field. SO PROUD!!!”
“Just when we thought WCLC24 couldn’t get better… we got an incredible presentation and puppies! Our furry friends came along to help lift spirits. Definitely an impactful and adorable highlight of Day 3.”
“Really exciting to watch Erica Warner present the initial results from the MGH FireHealthStudy.org at WCLC24.
Stay tuned to hear more soon! Also, we are looking for firefighters diagnosed with lung cancer to enroll – please refer such people to our website.”
“WCLC24 Going on now plenary session on Exploring the Rising Influence on Non-Tobacco Risk Factors, chaired by Linda Martin and patient advocate Dave Bjork.
First presentation on the impact of Climate Change on lung cancer outcomes and incidence by Leticia Nogueira.
We have 3 choices in climate change:
- Mitigation
- Adaptation
- Solutions
Next Clearing the Air: Unmasking Indoor Pollutants and Lung Cancer Risk by Roselle de Guzman from Manila.
- Air pollution is a global health issue
- many workers around the world still exposed to asbestos”
“More photos from the halls of IASLC WCLC24.
Karen Reckampand I were catching up when we corralled Minghua Lu to join us in a photo op! Loved the catching up!!”
“Dr. Geoffrey Liu presents data from TRUST-II, global phase II trial evaluating next-gen ROS1 TKI taletrectinib in patients with ROS1 NSCLC. PFS data – esp in 1L setting – awaited. Looking forward to additional data to be shared next week at ESMO. ”
“A huge thank you to Donna Short for attending my presentation and for the wonderful tweet! Your support means a lot and helps amplify our work.”
“WCLC24 Meet-up. Happy to meet Fabio Moraes
IASLCC WCLC24 Co-chair.
Congratulations and huge thanks for the greatest-ever conference.”
“Mission accomplished! Speaking at WLCC24 San Diego today, about Targeted therapies for NSCLC – The Patient’s Perspective.’ Proud to join a global team.”
“Wrapping up all the good things that I have lived through the IASLC 50th Anniversary. Best science, great friendships and strong collaboration across the globe to eradicate lung cancer everywhere and provide support to our patients and caregivers.”
“Congrats to Leah Backhus for winning the WCLC24 Robert J. Ginsberg Lectureship Award for Surgery on her crucial work using precision oncology to improve lung cancer surveillance, using machine learning to move away from a one-size-fits-all model and incorporate ctDNA, radiomics, etc.”
“Wrapping up WCLC24 with immense gratitude! A heartfelt thank you to Narjust Florez for opening so many doors and creating incredible opportunities. And a big shoutout to Laura Petrillo for her amazing partnership throughout the planning committee.”
“Great to be a part of the IASLC WCLC24 closing session on advancing patient advocacy worldwide. While spread across the world, we have 1 goal: improving outcomes for those with lung cancer. Thanks Dr Jhanelle Gray, Anabelle Gurwitch, Caleb Egwuenu, Shani Shilo and Lillian Leigh – fab session.”
“The amazing Narjust Florez presents Dana Farber Cancer Care Equity Program (CCEP)’s Lung Cancer Screening Initiative, making lung cancer screening smoking cessation services more accessible to vulnerable populations. CCEP enabled 85% of patients to complete 1st lung cancer screening!”
“Important presentation on patient level data from CM816 and CM77T. As always, PatrickForde gave a great presentation. I do believe this is a unique dataset that can answer some questions about the adjuvant component of ‘sandwich’ strategies.”
“Stay Tuned Lung Cancer Considered in Arabic IASLC.
Thank you Stephen V Liu.
The 4 episodes: Highlights from WCLC24, Chemo immunotherapy, Training the future thoracic oncologist and Arab Women in thoracic oncology.”
“Had a fun time today participating in a roundtable interview with DXY Media. The focus was on discussing career development opportunities within IASLC.
A topic close to my heart and important for early career investigators to be aware of. My esteemed colleagues Dr. Matthew Smeltzer, Dr. Wenzhao Zhong, Dr. Chunxue Bai, and I highlight our journey and the multiple avenues within IASLC to find mentorship, funding, and career development opportunities.”
“Simply AMAZING group – great to see everyone. Proud to lead with Gilberto Lopes the IASLC Global Policy and Partnership Committee – keep an eye of our activities that will showcase the policy aspect in lung cancer.”
“Well WCLC2024 is a wrap!
Sandip Patel, Narjust Florez and their cochairs as well as the IASLC staff – outstanding job! All of the presenters and faculty were stellar! Thanks for making this WCLC one to remember! IASLC family.”
“To reach a global audience, IASLC has recorded WCLC24 podcast episodes in world languages. In this Lung Cancer Considered episode, Chunxia Su moderates a discussion in Mandarin about highlights from the conference with Dr. Huijuan Wang, Dr. Lin Wu.”
“Starting now at IASLC WCLC24 Real World implementation of early lung cancer detection Narjust Florez discussing Bringing Equity to the Community the Dana Farber’s lung cancer screening initiative.”
“CAR-T cell in Lung Cancer: Hope or Hype?
Some early data of good results: Further results awaited
Targets of CAR T include GPC3, DLL3, ROR1, CEA, even ALK and EGFR
Nice summary by Ben Creelan at WCLC24.”
“IASLC Presidential FURTHER: A global, randomized study of Firmonertinib at 2 dose levels in TKI_naive, advanced NSCLC with EGFR PACC_mut
ORR %63.6 in 240 mg OD
Tox: the key is the dose.
Promissing CNS activity
Congrats Dr David Planchard! Great discussion Dr Alfredo Addeo!”
“Dr. Xiuning Le presents SOHO-01, BAY2927088 (oral TKI) in HER2 mut. Lung Cancer previously treatment with chemotherapy
-Promising ORR 72.1% with 1 CR
-mPFS 7.5 mo
-AEs: 86% diarrhea (G1-2), 25% with G3+ diarrhea
-31.8% required dose reductions and 3 patients had to discontinue due to TRAEs”
More posts featuring WCLC24 on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023